Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [360]

Pushing T cells down “memory lane” may improve cancer therapy

Pushing T cells down “memory lane” may improve cancer therapy

Researchers discover genes that predict good response to blood cancer therapy

Researchers discover genes that predict good response to blood cancer therapy

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene-edited therapy

EHA 2022: Transforming transfusion-dependent β-thalassemia and sickle cell disease with a single CRISPR/Cas9 gene...

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

$ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing sarcoma$

ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refractory ewing...

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Biological pathways found that drive genomic changes and bone metastasis in Ewing sarcoma, a rare childhood cancer

Biological pathways found that drive genomic changes and bone metastasis in Ewing sarcoma, a rare childhood cancer

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

More from ecancer